Abstract Details

Title Natural vs. Drug-Modified Cholesterol Levels and the Incidence of Ischemic Stroke

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 228

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Martin Constante, MD	No disclosure on file
Yedatore S. Venkatesh, MD, FAAN (University of SC School of Medicine)	Dr. Venkatesh has nothing to disclose.
Robert E. Hogan, MD (Washington Univ in St Louis/Neuro Dept)	Dr. Hogan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Hogan has received research support from Biogen Inc. The institution of Dr. Hogan has received research support from Engage Therapeutics. The institution of Dr. Hogan has received research support from Otsuka Pharmaceuticals. The institution of Dr. Hogan has received research support from Cerevel Therapeutics.

��ɫ����